FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2188371844> ?p ?o ?g. }

• W2188371844 endingPage "952" @default.
• W2188371844 startingPage "945" @default.
• W2188371844 abstract "Cisplatin is effective as a single agent or in combination with other drugs for the treatment of non-small cell lung cancer (NSCLC). A concerning clinical challenge with cisplatin-based NSCLC chemotherapy is the intrinsic and acquired chemoresistance to cisplatin. The sterile α motif domain-containing (SAMD9) gene has been reported as a potent tumor suppressor gene that inhibits tumorigenesis and progression of NSCLC. microRNAs (miRNA) have been revealed to play important roles in the regulation of cancer chemoresistance. To the best of our knowledge the present study explored the role of miRNA/SAMD9 signaling in regulating cisplatin chemoresistance in NSCLC for the first time. Out of the several candidate miRNAs predicted to bind the 3'-untranslated region (UTR) of the SAMD9 gene, miRNA-96 (miR-96) demonstrated significant target-sequence-specific inhibition of the SAMD9 3'-UTR luciferase reporter activity in NSCLC cells. In addition, while NSCLC tumor samples exhibited significantly higher expression levels of miR-96 compared with adjacent normal tissues, the expression levels of SAMD9 were significantly lower than those in adjacent normal tissues. miR-96 and SAMD9 were overexpressed and knocked down in the human NSCLC H358 and H23 cell lines and the half maximal inhibitory concentration (IC50) of cisplatin and cell apoptosis rate under cisplatin treatment were used as measures of cisplatin chemoresistance. The present results identified that overexpression of miR-96 in NSCLC cells markedly decreased SAMD9 expression and cisplatin-induced apoptosis, and increased the cisplatin IC50, which could be eliminated by overexpression of SAMD9. By contrast, knocking down miR-96 in NSCLC cells using antagomir-96 significantly increased SAMD9 expression and the cisplatin-induced apoptosis and decreased cisplatin IC50, which could be completely reversed by a knockdown of SAMD9. In conclusion, the current study demonstrates that miR-96 targets and downregulates SAMD9 in NSCLC, which decreases cisplatin-induced apoptosis and induces cisplatin chemoresistance in NSCLC cells. The findings of the present study add novel insights into the function of miR-96 and SAMD9 in cancer, as well as into the molecular mechanisms underlying NSCLC chemoresistance." @default.
• W2188371844 created "2016-06-24" @default.
• W2188371844 creator A5014177279 @default.
• W2188371844 creator A5058845432 @default.
• W2188371844 creator A5061078545 @default.
• W2188371844 creator A5064398090 @default.
• W2188371844 creator A5076585197 @default.
• W2188371844 creator A5086270619 @default.
• W2188371844 creator A5087210747 @default.
• W2188371844 date "2015-12-03" @default.
• W2188371844 modified "2023-10-17" @default.
• W2188371844 title "miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9" @default.
• W2188371844 cites W144423133 @default.
• W2188371844 cites W1872635974 @default.
• W2188371844 cites W1964539405 @default.
• W2188371844 cites W1973867232 @default.
• W2188371844 cites W1988156822 @default.
• W2188371844 cites W1993382872 @default.
• W2188371844 cites W2012108057 @default.
• W2188371844 cites W2020008959 @default.
• W2188371844 cites W2066976755 @default.
• W2188371844 cites W2069997185 @default.
• W2188371844 cites W2081452698 @default.
• W2188371844 cites W2109230191 @default.
• W2188371844 cites W2129835144 @default.
• W2188371844 cites W2132268606 @default.
• W2188371844 cites W2150576339 @default.
• W2188371844 cites W2161053574 @default.
• W2188371844 cites W2164435634 @default.
• W2188371844 doi "https://doi.org/10.3892/ol.2015.4000" @default.
• W2188371844 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4734049" @default.
• W2188371844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26893673" @default.
• W2188371844 hasPublicationYear "2015" @default.
• W2188371844 type Work @default.
• W2188371844 sameAs 2188371844 @default.
• W2188371844 citedByCount "52" @default.
• W2188371844 countsByYear W21883718442016 @default.
• W2188371844 countsByYear W21883718442017 @default.
• W2188371844 countsByYear W21883718442018 @default.
• W2188371844 countsByYear W21883718442019 @default.
• W2188371844 countsByYear W21883718442020 @default.
• W2188371844 countsByYear W21883718442021 @default.
• W2188371844 countsByYear W21883718442022 @default.
• W2188371844 countsByYear W21883718442023 @default.
• W2188371844 crossrefType "journal-article" @default.
• W2188371844 hasAuthorship W2188371844A5014177279 @default.
• W2188371844 hasAuthorship W2188371844A5058845432 @default.
• W2188371844 hasAuthorship W2188371844A5061078545 @default.
• W2188371844 hasAuthorship W2188371844A5064398090 @default.
• W2188371844 hasAuthorship W2188371844A5076585197 @default.
• W2188371844 hasAuthorship W2188371844A5086270619 @default.
• W2188371844 hasAuthorship W2188371844A5087210747 @default.
• W2188371844 hasBestOaLocation W21883718441 @default.
• W2188371844 hasConcept C104317684 @default.
• W2188371844 hasConcept C121608353 @default.
• W2188371844 hasConcept C126322002 @default.
• W2188371844 hasConcept C143998085 @default.
• W2188371844 hasConcept C145059251 @default.
• W2188371844 hasConcept C190283241 @default.
• W2188371844 hasConcept C2776256026 @default.
• W2188371844 hasConcept C2776694085 @default.
• W2188371844 hasConcept C2778239845 @default.
• W2188371844 hasConcept C2781018059 @default.
• W2188371844 hasConcept C29537977 @default.
• W2188371844 hasConcept C502942594 @default.
• W2188371844 hasConcept C54009773 @default.
• W2188371844 hasConcept C54355233 @default.
• W2188371844 hasConcept C55493867 @default.
• W2188371844 hasConcept C555283112 @default.
• W2188371844 hasConcept C71924100 @default.
• W2188371844 hasConcept C81885089 @default.
• W2188371844 hasConcept C86803240 @default.
• W2188371844 hasConceptScore W2188371844C104317684 @default.
• W2188371844 hasConceptScore W2188371844C121608353 @default.
• W2188371844 hasConceptScore W2188371844C126322002 @default.
• W2188371844 hasConceptScore W2188371844C143998085 @default.
• W2188371844 hasConceptScore W2188371844C145059251 @default.
• W2188371844 hasConceptScore W2188371844C190283241 @default.
• W2188371844 hasConceptScore W2188371844C2776256026 @default.
• W2188371844 hasConceptScore W2188371844C2776694085 @default.
• W2188371844 hasConceptScore W2188371844C2778239845 @default.
• W2188371844 hasConceptScore W2188371844C2781018059 @default.
• W2188371844 hasConceptScore W2188371844C29537977 @default.
• W2188371844 hasConceptScore W2188371844C502942594 @default.
• W2188371844 hasConceptScore W2188371844C54009773 @default.
• W2188371844 hasConceptScore W2188371844C54355233 @default.
• W2188371844 hasConceptScore W2188371844C55493867 @default.
• W2188371844 hasConceptScore W2188371844C555283112 @default.
• W2188371844 hasConceptScore W2188371844C71924100 @default.
• W2188371844 hasConceptScore W2188371844C81885089 @default.
• W2188371844 hasConceptScore W2188371844C86803240 @default.
• W2188371844 hasIssue "2" @default.
• W2188371844 hasLocation W21883718441 @default.
• W2188371844 hasLocation W21883718442 @default.
• W2188371844 hasLocation W21883718443 @default.
• W2188371844 hasLocation W21883718444 @default.
• W2188371844 hasOpenAccess W2188371844 @default.
• W2188371844 hasPrimaryLocation W21883718441 @default.

• next